Gene · 8019
Papers2,104
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,104
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Rare Case of Mediastinal NUT (Nuclear Protein in Testis) Carcinoma Presenting with Acute Respiratory Failure: A Case Report. | Int Med Case Rep J | 2026 | 41800272 | PubTator, text mining | PubMed |
| The oncolytic vesicular stomatitis virus VSV-GP shows profound oncolytic activity in NUT-carcinoma cell lines. | Mol Ther Oncol | 2026 | 41766922 | PubTator, text mining | PubMed |
| Detection of germline variants in human population chronically exposed to high level natural background radiation in Kerala coast. | Genes Environ | 2026 | 41761368 | PubTator, text mining | PubMed |
| Quinoxaline Derivatives in Cancer Therapy: Insights into Mechanisms of Action and Therapeutic Applications. | Biomol Ther (Seoul) | 2026 | 41755772 | PubTator, text mining | PubMed |
| Enhanced Antitumor Activity and Induction of Immunogenic Cell Death in NUT Carcinoma Cells by Combining Oncolytic Viruses with the Dual Inhibitor NEO2734. | Viruses | 2026 | 41754610 | PubTator, text mining | PubMed |
| Epigenetic Therapies for Inflammatory and Immune-Mediated Skin Diseases. | Biomedicines | 2026 | 41751272 | PubTator, text mining | PubMed |
| Enteric botulinum neurotoxins facilitate infection by Salmonella and Shigella. | Sci Adv | 2026 | 41739930 | PubTator, text mining | PubMed |
| International guidelines on the diagnosis and treatment of NUT carcinoma. | Innovation (Camb) | 2026 | 41737331 | PubTator, text mining | PubMed |
| Viability of Dugesia dorotocephala Planaria with the Senolytic Drug ARV-825. | MicroPubl Biol | 2026 | 41728347 | PubTator, text mining | PubMed |
| RuPHOTACs Provide Photocontrol Over Protein Degradation with Optimized Properties for Biological Applications. | Res Sq | 2026 | 41727614 | PubTator, text mining | PubMed |
| Semi-rigid linkers improve the pharmacokinetic properties and therapeutic efficacy of BET PROTACs for cancer therapy. | Eur J Med Chem | 2026 | 41687266 | PubTator, text mining | PubMed |
| Unraveling AMPK and BET regulation of immune checkpoint biology: implications for personalized medicine. | bioRxiv | 2026 | 41659635 | PubTator, text mining | PubMed |
| Primate lineage specification requires suppression of Alu hyperediting. | bioRxiv | 2026 | 41648576 | PubTator, text mining | PubMed |
| Developments and challenges in hit progression within fragment-based drug discovery. | Nat Commun | 2026 | 41620434 | PubTator, text mining | PubMed |
| Deciphering the regulatory landscape of enhancer RNAs in health and disease. | Signal Transduct Target Ther | 2026 | 41605892 | PubTator, text mining | PubMed |
| Epigenetic suppression of synovial inflammation and osteoclast differentiation in rheumatoid arthritis by I-BET762. | Sci Rep | 2026 | 41571822 | PubTator, text mining | PubMed |
| Correction: Hybrid AI/physics pipeline for miniprotein binder prioritization: application to the BRD3 ET domain. | Chem Commun (Camb) | 2026 | 41528089 | PubTator, text mining | PubMed |
| BET Isoform Selectivity through Diverse Linkers for Bivalent Inhibitors: GSK785, a BRD2/4-Selective Bivalent BET Inhibitor. | J Med Chem | 2026 | 41467648 | PubTator, text mining | PubMed |
| Development of cell-active BRD4-D1 selective inhibitors to decode the role of BET proteins in LPS-mediated liver inflammation. | Eur J Med Chem | 2026 | 41448046 | PubTator, text mining | PubMed |
| Primary Cutaneous NUT Adnexal Carcinoma: A Case Report With Novel Clinical and Pathological Observations. | J Cutan Pathol | 2026 | 41392342 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8019/papers?page=2